WTO TRIPS Council June 2015: Norway’s statement on Non-Violation and Situation Complaints
Norway delivered the following statement on non-violation and situation complaints at the June 2015 meeting of the WTO TRIPS Council.
As deliveredTRIPS COUNCIL MEETING 9 AND 10 JUNE 2015
6. NON-VIOLATION AND SITUATION COMPLAINTS
Statement by Norway
***
- We would like to join the overwhelming majority of members that have intervened today.
TRIPS Council June 2015: Norway provides unequivocal support of LDC Group request for extension of the transition period
On Wednesday, 10 June 2015, Norway – a high-income member of the WTO with a GDP per capita of 100,898 USD- (Source: World Bank, 2013) delivered this powerful intervention supporting the LDC Group request for an extension of the transition period for pharmaceutical products. On the LDC Group’s specific request on extension until graduation, Norway said,
WTO TRIPS Council (June 2015): India underscores the importance of de-linkage in discussions of financing innovation
In discussions at the June 2015 WTO TRIPS Council on the role of intellectual property in financing innovation, India underscored its commitment to the principle of de-linkage by stating,
Innovation should not be viewed within the narrow prism of intellectual property monopolies but framed within a holistic, knowledge ecosystem that includes open innovation, open knowledge approaches and de-linkage of R&D costs from product prices
WTO TRIPS Council (June 2015): India’s statement on Non-Violation and Situational Complaints
On Tuesday, 9 June 2015, India delivered the following statement on Non-Violation and Situational Complaints (IP/C/W/385/Rev 1). Brazil introduced the paper along with 16 other WTO members including India. The 17 co-sponsors of this paper include Argentina, Plurinational State of Bolivia, Brazil, China, Colombia, Cuba, Ecuador, Egypt, India, Indonesia, Kenya, Malaysia, Pakistan, Peru, Russian Federation, Sri Lanka and Bolivarian Republic of Venezuela.
The joint submission proposes the following action item for the Nairobi Ministerial from 15 December 2015 to 18 December 2015:
WTO TRIPS Council (June 2015): LDC Group Presentation on the Extension of the Decision for Pharmaceutical Products
The LDC Group delivered the following statement on Wednesday, 8 June 2015 during WTO TRIPS Council discussions on their request on the extension of the decision on pharmaceutical products.
PRESENTATION BY THE LDCS GROUP TO THE TRIPS COUNCIL ON THE EXTENSION OF THE DECISION ON PHARMACEUTICAL PRODUCTS, 09-10 JUNE 2015Mr. Chairman,
I make this presentation on behalf of the LDCs group. We thank you for calling this meeting and for your report.
WTO TRIPS Council: World Health Organization issues unequivocal support of LDC transition period for pharmaceutical products
Today, on Wednesday, 10 June 2015, the World Trade Organization’s TRIPS Council discussed the LDC Group’s Request for an Extension of the Transitional Period Under Article 66.1 of the TRIPS Agreement for Least Developed Country Members with Respect to Pharmaceutical Products and for Waivers from the Obligation of Articles 70.8 and 70.9 of the TRIPS Agreement (Source: IP/C/W/605). Continue Reading
WTO TRIPS Council (February 2015): EU statement on LDC extension of transition period for pharmaceutical products
The following statement was delivered by the European Union at the February 2015 session in response to the proposal by the LDC Group Request for an Extension of the Transitional Period Under Article 66.1 of the TRIPS Agreement for Least Developed Country Members with Respect to Pharmaceutical Products and for Waivers from the Obligation of Articles 70.8 and 70.9 of the TRIPS Agreement.
In particular, the European Union noted,
June 2015: WTO reports on India’s Section 3(d) and compulsory licensing provisions – WTO Trade Policy Review – India
On 2 June 2015 and 4 June 2015, the World Trade Organization (WTO) is conducting a trade policy review of India. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The TPRM takes place in the “Trade Policy Review Body which is actually the WTO General Council — comprising the WTO’s full membership — operating under special rules and procedures” (Source: WTO, Trade Policy Reviews: Brief Introduction).
WHA68: Statement of HAI/KEI on Follow-up to 2014 HLM on comprehensive review + assessment of prevention and control of NCDs
On Tuesday, 26 May 2015, the following statement was delivered in Committee B of the 68th World Health Assembly on behalf of Stichting Health Action International and Knowledge Ecology International on the topic: Follow-up to the 2014 high-level meeting of the United Nations General Assembly to undertake a comprehensive review and assessment of the progress achieved in the prevention and control of noncommunicable diseases.
May 21, 2015- Agenda for KEI/KEI Europe panel on Compulsory licensing of patents on drugs, vaccines and diagnostic tests
Panel discussion
Compulsory licensing of patents on drugs, vaccines and diagnostic testsKnowledge Ecology International (KEI) and Knowledge Ecology International Europe (KEI Europe):
DATE: Thursday, 21 May 2015
TIME: 17:30-19:00
VENUE: Kofi Annan Room, UNAIDS, Avenue Appia 20Moderator:
- Ellen ‘t Hoen, Medicines, Law and Policy
Panel members